Uncategorized
Mynosys Cellular Devices, Inc. Secures $25 Million Investment From Decheng Capital; Names Veteran Ophthalmic Executive Rob Thornhill as CEO
FREMONT, Calif.--(BUSINESS WIRE)--Mynosys Cellular Devices, manufacturer of the Zepto® cataract surgery device, finalized a $25 million financing round and named Rob Thornhill as CEO.